Theriva Biologics, Inc. Licenses Revenue (Deprecated 2018-01-31)
Theriva Biologics, Inc. (TOVX) reported Licenses Revenue (Deprecated 2018-01-31) of $0 for the 12-month period ending 2011-12-31, per its 10-K/A filed 2012-05-11.
Discontinued › Income Statement › Other Income
us-gaap:LicensesRevenue · last filed 2012-05-11
- Theriva Biologics, Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $0.00.
- Theriva Biologics, Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $0.00.
- Theriva Biologics, Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2010-12-31 was $0.00.
- Theriva Biologics, Inc. licenses revenue (deprecated 2018-01-31) for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- Theriva Biologics, Inc. licenses revenue (deprecated 2018-01-31) for fiscal 2010 was $2.13M.
| Period end | Licenses Revenue (Deprecated 2018-01-31) 3 month | Licenses Revenue (Deprecated 2018-01-31) 6 month | Licenses Revenue (Deprecated 2018-01-31) 9 month | Licenses Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-05-11 | $0.00 derived: sum of 2 quarters · filed 2012-05-11 | $0.00 derived: sum of 3 quarters · filed 2012-05-11 | $0.00 10-K/A · filed 2012-05-11 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 derived: sum of 2 quarters · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | $0.00 10-Q · filed 2011-08-15 | ||
| 2010-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-05-11 | $0.00 derived: sum of 2 quarters · filed 2012-05-11 | $2.13M derived: sum of 3 quarters · filed 2012-05-11 | $2.13M 10-K/A · filed 2012-05-11 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 | $2.13M derived: sum of 2 quarters · filed 2011-11-14 | $2.13M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $2.13M 10-Q · filed 2011-08-15 | $2.13M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |